Publication | Closed Access

In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48–positive Klebsiella pneumoniae strains

Klebsiella PneumoniaeAntimicrobial ChemotherapyKlebsiella Pneumoniae StrainsOxa 48–PositiveInfection ControlAntibacterial MechanismsAnti-infective AgentsAntimicrobial ResistanceAntimicrobial Drug DiscoveryAntibacterial AgentAntimicrobial PharmacokineticsAntimicrobial CompoundPharmacologyClinical MicrobiologyAntibioticsMicrobiologyAntimicrobial AgentsMedicineVitro Activity